Put companies on watchlist
Alzchem Group AG
ISIN: DE000A2YNT30
WKN: A2YNT3
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Alzchem Group AG · ISIN: DE000A2YNT30 · EQS - adhoc news (87 News)
Country: Germany · Primary market: Germany · EQS NID: 1956527
30 July 2024 09:21AM

Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024


EQS-Ad-hoc: Alzchem Group AG / Key word(s): Change in Forecast
Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024

30-Jul-2024 / 09:21 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024

Trostberg, July 30, 2024 – Alzchem Group AG is raising its earnings forecasts for fiscal year 2024. Group EBITDA will grow to over EUR 100 million with unchanged sales expectations (original forecast: approx. EUR 90 million). The raise in the EBITDA forecast leads to an increase in the EBITDA margin forecast from previously approx. 15.8% to over 17.5%.

The reason for the increase in the EBITDA forecast is the stronger growth and thus the shift in the product mix towards Specialty Chemicals.

The previous forecasts for the financial performance indicators group sales, inventories, inventory intensity and equity ratio remain unchanged. This results in the following picture for fiscal year 2024:

  2023 Original forecast 2024 Adjusted forecast 2024
Group sales EUR 540.6 million Growing to around EUR 570 million Growing to around EUR 570 million
Adjusted EBITDA* EUR 81.4 million Growing to around EUR 90 million Growing to over EUR 100 million
Adjusted EBITDA margin* 15.1% Growing to 15.8% Growing to over 17.5%
Inventories EUR 107.5 million Stable Stable
Inventory intensity 19.9% Stable Stable
Equity ratio 38.5% Growing strongly Growing strongly
* No adjustments were made


End of Inside Information

30-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone: +498621862888
Fax: +49862186502888
E-mail: ir@alzchem.com
Internet: www.alzchem.com
ISIN: DE000A2YNT30
WKN: A2YNT3
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 1956527

 
End of Announcement EQS News Service

1956527  30-Jul-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1956527&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - Alzchem Group AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.